ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Biodesix Inc

Biodesix Inc (BDSX)

0.81
0.0037
( 0.46% )
Actualizado: 09:29:14

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
2.500.040.050.040.0450.000.00 %0146-
5.000.001.950.000.000.000.00 %00-

Su centro para precios en tiempo real, ideas y debates en vivo

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
2.500.502.501.751.500.000.00 %02-
5.004.005.300.004.650.000.00 %00-

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SYRSSyros Pharmaceuticals Inc
US$ 0.2004
(118.78%)
559.23M
RAYRaytech Holding Ltd
US$ 1.81
(108.05%)
34.63M
TSVT2seventy bio Inc
US$ 4.95
(76.79%)
26.26M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.2434
(56.03%)
11.98M
DWTXDogwood Therapeutics Inc
US$ 11.90
(41.00%)
9.28M
WCTWellchange Holdings Company Limited
US$ 1.0201
(-59.36%)
9.35M
ARVNArvinas Inc
US$ 8.39
(-52.22%)
9.21M
LZMHLZ Technology Holdings Ltd
US$ 8.79
(-43.87%)
365.11k
SPGCSacks Parente Golf Inc
US$ 0.1032
(-35.54%)
23.54M
MDCXMedicus Pharma Ltd
US$ 2.501
(-26.44%)
38.62k
SYRSSyros Pharmaceuticals Inc
US$ 0.2004
(118.78%)
559.23M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0456
(36.12%)
312.75M
CUTRCutera Inc
US$ 0.1492
(16.11%)
190.55M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.81
(5.83%)
177.67M
AWHAspira Womans Health Inc
US$ 0.2233
(12.78%)
176.07M

BDSX Discussion

Ver más
georgie18 georgie18 6 días hace
BDSX...96...🥳

georgie18

Member Level
Re: georgie18 post# 18

Wednesday, March 05, 2025 12:01:26 PM

Post#
20
of 20
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
georgie18 georgie18 6 días hace
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 6 días hace
BDSX....SLOW GRIND TO A DOLLA
👍️0
georgie18 georgie18 6 días hace
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 7 días hace
BDSX BOTTOM BUSTER
👍️0
georgie18 georgie18 2 meses hace
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Mr Schuler is buying shares again
👍️0
tw0122 tw0122 4 meses hace
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
👍️0
tw0122 tw0122 4 meses hace
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
👍️0
AJ Freely AJ Freely 2 años hace
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 2 años hace
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 2 años hace
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 2 años hace
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 2 años hace
Earnings look good.
👍️0
subslover subslover 2 años hace
Earnings look good.
👍️0
MiamiGent MiamiGent 2 años hace
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 2 años hace
Not so much...
👍️0
crudeoil24 crudeoil24 3 años hace
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 3 años hace
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 3 años hace
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 3 años hace
US based company is quietly trending up. IMHO.
GLTA
👍️0